1. Home
  2. VNET vs SRPT Comparison

VNET vs SRPT Comparison

Compare VNET & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VNET Group Inc.

VNET

VNET Group Inc.

HOLD

Current Price

$9.49

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$17.15

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNET
SRPT
Founded
1999
1980
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.4B
IPO Year
2011
2000

Fundamental Metrics

Financial Performance
Metric
VNET
SRPT
Price
$9.49
$17.15
Analyst Decision
Strong Buy
Hold
Analyst Count
1
28
Target Price
$12.60
$25.76
AVG Volume (30 Days)
6.8M
2.0M
Earning Date
03-16-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,198,237,000.00
Revenue This Year
$19.42
N/A
Revenue Next Year
$19.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.58
52 Week Low
$4.65
$10.42
52 Week High
$14.48
$80.26

Technical Indicators

Market Signals
Indicator
VNET
SRPT
Relative Strength Index (RSI) 40.33 45.46
Support Level $9.40 $17.05
Resistance Level $11.78 $19.55
Average True Range (ATR) 0.61 0.83
MACD -0.16 0.13
Stochastic Oscillator 14.86 63.11

Price Performance

Historical Comparison
VNET
SRPT

About VNET VNET Group Inc.

VNET started as AsiaCloud in 1999 and moved into the data center business, opening its first self-developed data center in 2010. The firm listed (as 21Vianet) on the Nasdaq in April 2011, subsequently changing its name to VNET Group in 2021. It originally focused on providing data center services such as colocation and cloud services to retail clients in China, but added hyperscale customers in 2019 and now counts large Chinese hyperscalers such as Alibaba Cloud, Tencent Cloud, and Huawei Cloud as customers. At the end of September 2025, it had 52,288 retail cabinets, with the majority in Beijing, Shanghai, and the Greater Bay area. It also had 783 MW of wholesale capacity in service, with a further 306 MW under construction and a further 705 MW held for future development.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: